This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Tuesday's Small-Cap Winners & Losers

Small-cap stocks were buoyant Tuesday on the power of the climbing broad market and good news out of a few sectors.

United Retail Group (URGI) was a big winner, skyrocketing more than 77% on word Redcats Group agreed to buy the plus-size women's-apparel retailer for $13.70 a share -- an 81.5% premium to Monday's closing price. The $198.9 million all-cash deal should close by year-end. Shares of the Rochelle Park, N.J., company gained $5.85 to $13.40.

Nabi Biopharmaceuticals (NABI) shot up 20.9% after agreeing to sell its Biologics strategic-business unit to Germany's Biotest Pharmaceuticals for $185 million. The deal includes the unit's products, certain of Nabi's Corporate Shared Services group assets, and the company's headquarters, among other things.

After the deal closes -- likely in the fourth quarter -- Nabi will shift its headquarters to an existing facility in Rockville, Md. Shares gained 72 cents to $4.16.

Meanwhile, G-III Apparel (GIII - Get Report) surged 20.2% after narrowing its fiscal second-quarter loss by nearly two-thirds from last year to a nickel a share, or $884,000. That shatters Thomson Financial's expectations for a 20-cent per-share loss. The New York-based company also added 8 cents to its full-year income outlook range, now expecting 98 cents to $1.03 a share. Analysts are seeking 95 cents. Shares were trading at $20.57.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs